The Zacks Analyst Blog Highlights Broadcom, T-Mobile, Abbott Laboratories, CBL & Associates Properties and Crown Crafts
Werte in diesem Artikel
For Immediate ReleaseChicago, IL – September 9, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Broadcom Inc. AVGO, T-Mobile US, Inc. TMUS, Abbott Laboratories ABT, CBL & Associates Properties, Inc. CBL and Crown Crafts, Inc. CRWS.Here are highlights from Monday’s Analyst Blog:Top Research Reports for Broadcom, T-Mobile and AbbottThe Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Broadcom Inc., T-Mobile US, Inc. and Abbott Laboratories, as well as two micro-cap stocks CBL & Associates Properties, Inc. and Crown Crafts, Inc.. The Zacks microcap research is unique as our research content on these small and under-the-radar companies is the only research of its type in the country.These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.You can see all of today's research reports here >>>Ahead of Wall StreetThe daily 'Ahead of Wall Street' article is a must-read for all investors who would like to be ready for that day's trading action. The article comes out before the market opens, attempting to make sense of that morning's economic releases and how they will affect that day's market action. You can read this article for free on our home page and can actually sign up there to get an email notification as this article comes out each morning.You can read today's AWS here >>> CPI, PPI This Week - Also ORCL, ADBE EarningsToday's Featured Research ReportsBroadcom's shares have outperformed the Zacks Electronics - Semiconductors industry over the year-to-date period (+51.5% vs. +27.8%). The company is experiencing strong momentum fueled by growth in AI semiconductors and continued success with its VMware integration. Strong demand for its networking products and custom AI accelerators (XPUs) has been noteworthy.Broadcom's AI segment benefits from custom accelerators and advanced networking technology that supports large-scale AI deployments with improved performance and efficiency. Broadcom expects fourth-quarter fiscal 2025 AI revenues to jump 66% year over year to $6.2 billion. The acquisition of VMware has benefited Infrastructure software solutions.As of the fiscal third quarter, roughly more than 90% of Broadcom's largest 10,000 customers have adopted VCF. However, gross margin in the fiscal fourth quarter is expected to contract sequentially. High debt level is a headwind.(You can read the full research report on Broadcom here >>>)Shares of T-Mobile have gained +10.8% over the year-to-date period against the Zacks Wireless National industry's gain of +20.1%. The company continues to boast a leadership position in the 5G market. T-Mobile's 5G network covers 98% of Americans, or 330 million people in the country. Its acquisition strategy has significantly strengthened its position in the wireless industry over the past few years.TMUS' 2.5 GHz 5G spectrum delivers superfast speeds and extensive coverage with signals that go through walls and trees. This boosts its competitive edge against companies that provide 5G networks controlled by the mmWave spectrum.However, owing to the stock's premium valuation, we believe investors should remain cautious as macroeconomic factors, market saturation, or economic downturns can significantly impact overvalued stocks like TMUS. Fierce competition is straining profitability. The high debt burden remains a major concern.(You can read the full research report on T-Mobile here >>>)Abbott's shares have outperformed the Zacks Medical - Products industry over the year-to-date period (+19.2% vs. +8.9%). The company's strong pipeline is opening up new growth opportunities, supporting the company's positive momentum and strong growth outlook for 2025. Freestyle Libre, Lingo and Libre Rio CGM devices are on a great trajectory.Alinity, the company's next-generation suite of systems, is a key driver in the core lab diagnostics business. The company is optimistic about its latest progress with biosimilars and expects this to significantly boost EPD sales through 2025. Within Nutrition, despite softness in the international pediatric arm, Abbott is regaining market share banking on strong Adult Nutrition business.Yet, the significant runoff of COVID-19 testing-related sales is hurting Abbott's Diagnostics growth. Headwinds such as tough macro conditions, tariffs and foreign exchange also add to the worry.(You can read the full research report on Abbott here >>>)Shares of CBL & Associates Properties' have outperformed the Zacks REIT and Equity Trust - Retail industry over the past year (+37.8% vs. -0.2%). This microcap company with a market capitalization of $989.86 million is executing a capital recycling strategy that enhances portfolio quality and cash flows, highlighted by $162.7 million of asset sales and $178.9 million in mall acquisitions that are immediately accretive to adjusted FFO and free cash flow per share.A fully non-recourse, long-dated debt profile strengthens liquidity and reduces refinancing risk, while $90 million–$100 million of amortization in 2025 supports deleveraging. A 5.1% dividend yield, backed by $288 million liquidity and balance sheet flexibility, appeals to income investors.Leasing momentum and positive spreads on new tenants underpin NOI durability, though renewal rent declines, tenant bankruptcies and ongoing same-center NOI contraction remain headwinds. High payout ratios and $2.15 billion leverage heighten refinancing dependence. The valuation offers value with execution risks.(You can read the full research report on CBL & Associates Properties here >>>)Crown Crafts' shares have underperformed the Zacks Textile - Home Furnishing industry over the past year (-27.2% vs. -1.2%). This microcap company with a market capitalization of $32.17 million sees its margin pressure persisting due to tariffs and elevated costs, although pricing actions, inventory discipline, and warehouse consolidation aim to stabilize profitability. Initiatives in licensed diaper bags, Stella dolls and international expansion provide growth levers.Risks include tariff sensitivity, retailer concentration, inventory misalignment, license expirations and dividend sustainability amid margin compression and leverage constraints. The valuation suggests investors are pricing in prolonged margin pressure, while overlooking potential upside from diversification.Nevertheless, Crown Crafts is leveraging its Baby Boom acquisition to diversify beyond core softness, adding $2.1 million in first-quarter fiscal 2026 sales, with access to premium licenses and broader retail distribution. Cash flow remains resilient, supporting self-funded growth and dividends.(You can read the full research report on Crown Crafts here >>>)Media ContactZacks Investment Research800-767-3771 ext. 9339support@zacks.com https://www.zacks.com Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.Quantum Computing Stocks Set To SoarArtificial intelligence has already reshaped the investment landscape, and its convergence with quantum computing could lead to the most significant wealth-building opportunities of our time.Today, you have a chance to position your portfolio at the forefront of this technological revolution. In our urgent special report, Beyond AI: The Quantum Leap in Computing Power, you'll discover the little-known stocks we believe will win the quantum computing race and deliver massive gains to early investors.Access the Report Free Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Abbott Laboratories (ABT): Free Stock Analysis Report CBL & Associates Properties, Inc. (CBL): Get Free Report Broadcom Inc. (AVGO): Free Stock Analysis Report T-Mobile US, Inc. (TMUS): Free Stock Analysis Report Crown Crafts, Inc. (CRWS): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: Abbott Laboratories und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!
Ausgewählte Hebelprodukte auf Abbott Laboratories
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Abbott Laboratories
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Deutsche Telekom AG
Analysen zu Deutsche Telekom AG
Datum | Rating | Analyst | |
---|---|---|---|
04.09.2025 | Deutsche Telekom Overweight | JP Morgan Chase & Co. | |
26.08.2025 | Deutsche Telekom Kaufen | DZ BANK | |
12.08.2025 | Deutsche Telekom Kaufen | DZ BANK | |
11.08.2025 | Deutsche Telekom Buy | UBS AG | |
08.08.2025 | Deutsche Telekom Buy | Deutsche Bank AG |
Datum | Rating | Analyst | |
---|---|---|---|
04.09.2025 | Deutsche Telekom Overweight | JP Morgan Chase & Co. | |
26.08.2025 | Deutsche Telekom Kaufen | DZ BANK | |
12.08.2025 | Deutsche Telekom Kaufen | DZ BANK | |
11.08.2025 | Deutsche Telekom Buy | UBS AG | |
08.08.2025 | Deutsche Telekom Buy | Deutsche Bank AG |
Datum | Rating | Analyst | |
---|---|---|---|
26.11.2024 | Deutsche Telekom Neutral | UBS AG | |
14.11.2024 | Deutsche Telekom Neutral | UBS AG | |
14.10.2024 | Deutsche Telekom Neutral | UBS AG | |
10.10.2024 | Deutsche Telekom Neutral | UBS AG | |
10.09.2024 | Deutsche Telekom Neutral | UBS AG |
Datum | Rating | Analyst | |
---|---|---|---|
30.03.2020 | Deutsche Telekom Underweight | Barclays Capital | |
18.03.2020 | Deutsche Telekom Underweight | Barclays Capital | |
04.03.2020 | Deutsche Telekom Underweight | Barclays Capital | |
20.02.2020 | Deutsche Telekom verkaufen | Barclays Capital | |
19.02.2020 | Deutsche Telekom Underperform | Jefferies & Company Inc. |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Deutsche Telekom AG nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen